$6.050
-1.130 (-18.68%)Zum Schluss
- Hoch
- 7.445
- Eröffnung
- 7.360
- Volumengewichteter Durchschnittskurs
- 6.45
- Volumen
- 527.23K
- Marktkap.
- —
- Tief
- 5.850
- Umsatz
- 3.40M
- EV/EBITDA, TTM
- -0.03
Axe Compute Inc. is a virtual neocloud AI infrastructure platform. The Company provides customers with access to graphics processing unit (GPU) compute capacity for artificial intelligence (AI) and other high-performance computing workloads through a distributed network model, including infrastructure made available through the Aethir network. It also operates a digital asset treasury focused on the Aethir token (ATH), the native utility token of the Aethir network. Its segments include Compute Services and Treasury Management and Drug Discovery Services. Its Drug Discovery Services segment provides services that include the application of AI using its proprietary biobank of tumor samples, as well as creation of proprietary 3D culture models used in drug development. The Company provides enterprises and AI innovators with flexibility across hardware, geography, and deployment models through two offerings: Axe Compute Access and Axe Compute Build.
KI-Analyse of Axe Compute Inc (AGPU)
HaltenAxe Compute Inc is currently not a strong buy due to its low RSI of 31.092 indicating oversold conditions, and a significant recent drop of 41.42% over the last 20 days. While the stock has a potential upside with an analyst price target of $20, the current price of $7.61 suggests that investors should wait for more stability before entering.
Bewertungskennzahlen
Event-Zeitleiste
News
2.011-04NewsfilterTech Stocks Surge After Midterm Elections Victory
4.511-04CNBCTech Stocks Surge Following Midterm Election Results
4.510-29NewsfilterAxe Compute Relocates Headquarters to Miami
5.010-21NewsfilterAxe Compute Grants Stock Options to New Employees
7.510-14NewsfilterAxe Compute Partners with Penguin Solutions to Accelerate AI Infrastructure Deployment
AGPU FAQ – beantwortet von Alphio AI
Axe Compute Inc. is a virtual neocloud AI infrastructure platform. The Company provides customers with access to graphics processing unit (GPU) compute capacity for artificial intelligence (AI) and other high-performance computing workloads through a distributed network model, including infrastructure made available through the Aethir network. It also operates a digital asset treasury focused on the Aethir token (ATH), the native utility token of the Aethir network. Its segments include Compute Services and Treasury Management and Drug Discovery Services. Its Drug Discovery Services segment provides services that include the application of AI using its proprietary biobank of tumor samples, as well as creation of proprietary 3D culture models used in drug development. The Company provides enterprises and AI innovators with flexibility across hardware, geography, and deployment models through two offerings: Axe Compute Access and Axe Compute Build. It operates in the Healthcare sector.
Axe Compute Inc is currently not a strong buy due to its low RSI of 31.092 indicating oversold conditions, and a significant recent drop of 41.42% over the last 20 days. While the stock has a potential upside with an analyst price target of $20, the current price of $7.61 suggests that investors should wait for more stability before entering.
Community
Mehr ↗Noch keine Beiträge
Registriere dich oder melde dich an, um mitzudiskutierenÄhnliche Artikel
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.